<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34800171</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>269</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>TBK1 haploinsufficiency results in changes in the K63-ubiquitination profiles in brain and fibroblasts from affected and presymptomatic mutation carriers.</ArticleTitle><Pagination><StartPage>3037</StartPage><EndPage>3049</EndPage><MedlinePgn>3037-3049</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-021-10887-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Frontotemporal dementia (FTD) is a neurodegenerative disease, resulting in progressive problems in language and/or behaviour and is often diagnosed before 65&#xa0;years of age. Ubiquitin positive protein aggregates in the brain are among the key pathologic hallmarks of frontotemporal lobar degeneration (FTLD) postmortem. The TANK-binding kinase 1 gene (TBK1) is on the list of genes that can contribute to the development of FTD as well as the related neurodegenerative disease amyotrophic lateral sclerosis (ALS).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this study, using an array of clinical and neuropathological data combined with biochemical and proteomics assays, we analyze the TBK1 splice-mutation (c.1340&#x2009;+&#x2009;1G&#x2009;&gt;&#x2009;A) in a Swedish family with a history of FTD and ALS. We also explore the K63 ubiquitination landscape in post-mortem brain tissue and fibroblast cultures.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The intronic (c.1340&#x2009;+&#x2009;1G&#x2009;&gt;&#x2009;A) mutation in TBK1 results in haploinsufficiency and affects the activity of the protein in symptomatic and pre-symptomatic mutation carriers.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results suggest that the mutation leads to a significant reduction of TBK1 activity and induce alterations in K63 ubiquitination profile of the cell already in the presymptomatic stages.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khoshnood</LastName><ForeName>Behzad</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8234-4389</Identifier><AffiliationInfo><Affiliation>Division for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. behzad.khoshnood@ki.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit for Hereditary Dementias, Karolinska University Hospital Solna, Stockholm, Sweden. behzad.khoshnood@ki.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swedish FTD Initiative, Stockholm, Sweden. behzad.khoshnood@ki.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ullgren</LastName><ForeName>Abbe</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit for Hereditary Dementias, Karolinska University Hospital Solna, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swedish FTD Initiative, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laffita-Mesa</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit for Hereditary Dementias, Karolinska University Hospital Solna, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swedish FTD Initiative, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;ijerstedt</LastName><ForeName>Linn</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit for Hereditary Dementias, Karolinska University Hospital Solna, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swedish FTD Initiative, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patra</LastName><ForeName>Kalicharan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit for Hereditary Dementias, Karolinska University Hospital Solna, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swedish FTD Initiative, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nennesmo</LastName><ForeName>Inger</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pathology, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graff</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. caroline.graff@ki.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit for Hereditary Dementias, Karolinska University Hospital Solna, Stockholm, Sweden. caroline.graff@ki.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swedish FTD Initiative, Stockholm, Sweden. caroline.graff@ki.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>VR 2018-02754</GrantID><Agency>vetenskapsr&#xe5;det</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C403191">TBK1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057895" MajorTopicYN="N">Haploinsufficiency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Autophagy</Keyword><Keyword MajorTopicYN="N">FTD</Keyword><Keyword MajorTopicYN="N">FTLD</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Haploinsufficiency</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">TBK1</Keyword><Keyword MajorTopicYN="N">Ubiquitination</Keyword></KeywordList><CoiStatement>We declare that we have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>20</Day><Hour>12</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34800171</ArticleId><ArticleId IdType="pmc">PMC9120096</ArticleId><ArticleId IdType="doi">10.1007/s00415-021-10887-x</ArticleId><ArticleId IdType="pii">10.1007/s00415-021-10887-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Piguet O, Hornberger M, Mioshi E, Hodges JR (2011) Behavioural-variant frontotemporal dementia: Diagnosis, clinical staging, and management. Lancet Neurol 10: 162&#x2013;72. Available from: https://pubmed.ncbi.nlm.nih.gov/21147039/</Citation><ArticleIdList><ArticleId IdType="pubmed">21147039</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden J, Mann D (2005) Frontotemporal dementia. Lancet Neurol 4: 771&#x2013;780. Available from: https://pubmed.ncbi.nlm.nih.gov/16239184/</Citation><ArticleIdList><ArticleId IdType="pubmed">16239184</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore KM, Nicholas J, Grossman M, McMillan CT, Irwin DJ, Massimo L, et al. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurol. 2020;19(2):145&#x2013;156. doi: 10.1016/S1474-4422(19)30394-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30394-1</ArticleId><ArticleId IdType="pmc">PMC7007771</ArticleId><ArticleId IdType="pubmed">31810826</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano I (2012) Frontotemporal lobar degeneration (FTLD)&#x2014;changes of its concept and classification based on aggregated proteins. In: Clinical Neurology. Rinsho Shinkeigaku: 1218&#x2013;20. Available from: https://pubmed.ncbi.nlm.nih.gov/23196569/</Citation><ArticleIdList><ArticleId IdType="pubmed">23196569</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Zee J, Van Broeckhoven C (2014) Dementia in 2013: Frontotemporal lobar degeneration-building on breakthroughs. Nat Rev Neurol 10: 70&#x2013;72. Available from: https://pubmed.ncbi.nlm.nih.gov/24394289/</Citation><ArticleIdList><ArticleId IdType="pubmed">24394289</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130&#x2013;133. Available from: https://pubmed.ncbi.nlm.nih.gov/17023659/</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Greaves CV, Rohrer JD. An update on genetic frontotemporal dementia. J Neurol. 2019;266:2075&#x2013;2086. doi: 10.1007/s00415-019-09363-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09363-4</ArticleId><ArticleId IdType="pmc">PMC6647117</ArticleId><ArticleId IdType="pubmed">31119452</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, M&#xfc;ller K, Ludolph AC, Weishaupt JH, Andersen PM (2017) Association of mutations in TBK1 with sporadic and familial amyotrophic lateral sclerosis and frontotemporal dementia. JAMA Neurol 74(1):110&#x2013;113. Available from: https://pubmed.ncbi.nlm.nih.gov/27892983/</Citation><ArticleIdList><ArticleId IdType="pubmed">27892983</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad L, Zhang SY, Casanova JL, Sancho-Shimizu V (2016) Human TBK1: a gatekeeper of neuroinflammation. Trends Mol Med 22: 511&#x2013;527. Available from: https://pubmed.ncbi.nlm.nih.gov/27211305/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4890605</ArticleId><ArticleId IdType="pubmed">27211305</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves A, B&#xfc;rckst&#xfc;mmer T, Dixit E, Scheicher R, G&#xf3;rna MW, Karayel E, et al (2011) Functional dissection of the TBK1 molecular network. PLoS One 6(9): e23971. Available from: https://pubmed.ncbi.nlm.nih.gov/21931631/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3169550</ArticleId><ArticleId IdType="pubmed">21931631</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N, Hara T (2006) Intracellular quality control by autophagy: How does autophagy prevent neurodegeneration? Autophagy 2(4):302&#x2013;324. Available from: https://pubmed.ncbi.nlm.nih.gov/16874082/</Citation><ArticleIdList><ArticleId IdType="pubmed">16874082</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans CS, Holzbaur ELF. Quality control in neurons: mitophagy and other selective autophagy mechanisms. J Mol Biol. 2020;432:240&#x2013;260. doi: 10.1016/j.jmb.2019.06.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2019.06.031</ArticleId><ArticleId IdType="pmc">PMC6946890</ArticleId><ArticleId IdType="pubmed">31295455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kragh CL, Ubhi K, Wyss-Corey T, Masliah E (2012) Autophagy in dementias. In: Brain Pathology. NIH Public Access 99&#x2013;109. Available from: /pmc/articles/PMC3243049</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243049</ArticleId><ArticleId IdType="pubmed">22150925</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z, Sheehan P, Chen S, Yue Z (2017) Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease? Mol Neurodegeneration 12. Available from: /pmc/articles/PMC5746010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5746010</ArticleId><ArticleId IdType="pubmed">29282133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishore N, Khai Huynh Q, Mathialagan S, Hall T, Rouw S, Creely D, et al (2002) IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2. Comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2. J Biol Chem 277(16):13840&#x2013;13847. Available from: https://pubmed.ncbi.nlm.nih.gov/11839743/</Citation><ArticleIdList><ArticleId IdType="pubmed">11839743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X, Helgason E, Phung QT, Quan CL, Iyer RS, Lee MW, et al (2012) Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation. Proc Natl Acad Sci U S A 109(24):9378&#x2013;9383. Available from: https://pubmed.ncbi.nlm.nih.gov/22619329/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3386122</ArticleId><ArticleId IdType="pubmed">22619329</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo JM, Ordureau A, Paulo JA, Rinehart J, Harper JW (2015) The PINK1-PARKIN Mitochondrial Ubiquitylation Pathway Drives a Program of OPTN/NDP52 Recruitment and TBK1 Activation to Promote Mitophagy. Mol Cell 60(1):7&#x2013;20. Available from: https://pubmed.ncbi.nlm.nih.gov/26365381/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4592482</ArticleId><ArticleId IdType="pubmed">26365381</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, et al (2011) Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333(6039):228&#x2013;233. Available from: https://pubmed.ncbi.nlm.nih.gov/21617041/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3714538</ArticleId><ArticleId IdType="pubmed">21617041</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilli M, Arko-Mensah J, Ponpuak M, Roberts E, Master S, Mandell MA, et al (2012) TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity 37(2):223&#x2013;234. Available from: https://pubmed.ncbi.nlm.nih.gov/22921120/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428731</ArticleId><ArticleId IdType="pubmed">22921120</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto G, Wada K, Okuno M, Kurosawa M, Nukina N (2011) Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell 44(2):279&#x2013;289. Available from: https://pubmed.ncbi.nlm.nih.gov/22017874/</Citation><ArticleIdList><ArticleId IdType="pubmed">22017874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohtake F, Saeki Y, Ishido S, Kanno J, Tanaka K (2016) The K48-K63 Branched Ubiquitin Chain Regulates NF-&#x3ba;B Signaling. Mol Cell 64(2):251&#x2013;266. Available from: https://pubmed.ncbi.nlm.nih.gov/27746020/</Citation><ArticleIdList><ArticleId IdType="pubmed">27746020</ArticleId></ArticleIdList></Reference><Reference><Citation>Husnjak K, Dikic I (2012) Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu Rev Biochem 81:291&#x2013;322. Available from: https://pubmed.ncbi.nlm.nih.gov/22482907/</Citation><ArticleIdList><ArticleId IdType="pubmed">22482907</ArticleId></ArticleIdList></Reference><Reference><Citation>Komander D, Rape M (202) The ubiquitin code. Annu Rev Biochem 81:203&#x2013;229. Available from: https://pubmed.ncbi.nlm.nih.gov/22524316/</Citation><ArticleIdList><ArticleId IdType="pubmed">22524316</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter B, Sliter DA, Herhaus L, Stolz A, Wang C, Beli P, et al (2016) Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc Natl Acad Sci U S A 113(15):4039&#x2013;4044. Available from: https://pubmed.ncbi.nlm.nih.gov/27035970/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4839414</ArticleId><ArticleId IdType="pubmed">27035970</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, M&#xfc;ller K, et al (2015) Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 18(5):631&#x2013;636. Available from: https://pubmed.ncbi.nlm.nih.gov/25803835/</Citation><ArticleIdList><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee J, Gijselinck I, Van Mossevelde S, Perrone F, Dillen L, Heeman B, et al (2017) TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Hum Mutat 38(3):297&#x2013;309. Available from: https://pubmed.ncbi.nlm.nih.gov/28008748/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5324646</ArticleId><ArticleId IdType="pubmed">28008748</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer JD, Warren JD, Fox NC, Rossor MN (2013) Presymptomatic studies in genetic frontotemporal dementia. In: Revue Neurologique. Rev Neurol: 820&#x2013;824. Available from: https://pubmed.ncbi.nlm.nih.gov/24012408/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3878569</ArticleId><ArticleId IdType="pubmed">24012408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kean MJ, Couzens AL, Gingras AC (2012) Mass spectrometry approaches to study mammalian kinase and phosphatase associated proteins. Methods57: 400&#x2013;408. Available from: https://pubmed.ncbi.nlm.nih.gov/22710030/</Citation><ArticleIdList><ArticleId IdType="pubmed">22710030</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76(11):1006&#x2013;1014. Available from: https://pubmed.ncbi.nlm.nih.gov/21325651/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134(9):2456&#x2013;2477. Available from: https://pubmed.ncbi.nlm.nih.gov/21810890/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, Porta S, Michael Baer G, Xu Y, Suh ER, Kwong LK, et al (2017) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134(1):65&#x2013;78. Available from: https://pubmed.ncbi.nlm.nih.gov/28130640/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5521959</ArticleId><ArticleId IdType="pubmed">28130640</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan JMM, Wong ESP, Kirkpatrick DS, Pletnikova O, Ko HS, Tay SP, et al (2008) Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum Mol Genet 17(3):431&#x2013;439. Available from: https://academic.oup.com/hmg/article/17/3/431/599942</Citation><ArticleIdList><ArticleId IdType="pubmed">17981811</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung CG, Lee H, Lee SB (2018) Mechanisms of protein toxicity in neurodegenerative diseases. Cell Mol Life Sci 75: 3159&#x2013;3180. Available from: /pmc/articles/PMC6063327/?report=abstract</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6063327</ArticleId><ArticleId IdType="pubmed">29947927</ArticleId></ArticleIdList></Reference><Reference><Citation>Tramutola A, Triani F, Di Domenico F, Barone E, Cai J, Klein JB, Perluigi M, Butterfield DA. Poly-ubiquitin profile in Alzheimer disease brain. Neurobiol Dis. 2018;118:129&#x2013;141. doi: 10.1016/j.nbd.2018.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.07.006</ArticleId><ArticleId IdType="pubmed">30003951</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter B, Sliter DA, Herhaus L, Stolz A, Wang C, Beli P, et al (2016) Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc Natl Acad Sci USA 113(15):4039&#x2013;4044. Available from: www.pnas.org/lookup/suppl/. doi:10.1073/pnas.1523926113/-/DCSupplemental</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4839414</ArticleId><ArticleId IdType="pubmed">27035970</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>